Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CAN/CSA Z18778-08: Technical Requirements and Compliance for Infant Monitors
Understanding the Canadian Adoption of ISO 18778 for Cardiorespiratory Monitoring of Infants
Scope and Application
CAN/CSA Z18778-08, Respiratory Equipment — Infant Monitors — Particular Requirements, is the Canadian adoption of the international standard ISO 18778:2008. It applies to infant monitors designed for home and professional healthcare environments that continuously monitor one or more physiological parameters — including respiration (apnea), heart rate, and peripheral oxygen saturation (SpO2) — and generate alarms when preset thresholds are exceeded. The standard covers devices intended for children up to three years of age.
This standard supplements the general safety and essential performance requirements of IEC 60601-1:2005 and its collateral standards. Manufacturers must demonstrate that their monitor meets these particular requirements in conjunction with the base standard to claim conformity with CAN/CSA Z18778-08.
Tip: Although CAN/CSA Z18778-08 is identical in technical content to ISO 18778:2008, Canadian regulations may impose additional labeling and language requirements (e.g., bilingual French/English instructions). Always verify current Health Canada guidance.
Technical Requirements for Performance and Safety
Classification of Monitors
CAN/CSA Z18778-08 defines three classes of infant monitors based on the parameters monitored and their clinical context:
| Class | Monitored Parameters | Essential Performance Requirements |
|---|---|---|
| Class I | Apnea (via respiratory sensor) | Apnea alarm within 20 seconds of detection; respiratory rate display within ±5 br/min |
| Class II | Apnea + bradycardia (HR) | As Class I plus: bradycardia alarm (threshold manufacturer-specified, within ±3 bpm); heart rate accuracy ±2 bpm or ±10% |
| Class III | Apnea + bradycardia + hypoxemia (SpO2) | As Class II plus: SpO2 alarm (threshold ≤ 85% saturation); accuracy per ISO 80601-2-61 |
Alarm Requirements
The standard prescribes strict alarm conditions. For apnea, the alarm must be activated after a period of absent breathing that does not exceed 20 seconds. For bradycardia, the alarm must trigger within 6 seconds of the heart rate falling below the programmable threshold. Tachycardia and SpO2 low alarms follow similar timing constraints. All alarms must be distinct, persistent, and visible on the operator interface. The monitor must also detect and reject motion artifact to minimize false alarms.
Sensor and Accuracy Specifications
CAN/CSA Z18778-08 requires that sensors for respiration and heart rate be validated against clinical reference methods (e.g., pneumotachography for respiration, ECG for heart rate). The standard mandates that the monitor automatically identify disconnected sensors or signal loss and activate an alarm within 10 seconds. For SpO2 measurement, the pulse oximeter sub-system must comply with ISO 80601-2-61 and be capable of alarm limits as low as 70% SpO2.
Warning: False alarms — especially for apnea — are a known problem in infant monitoring. During design, manufacturers should implement artifact rejection algorithms that meet the sensitivity/specificity requirements of the standard without compromising patient safety.
Implementation Highlights
To achieve compliance with CAN/CSA Z18778-08, manufacturers must address several key areas during product development:
- Risk management — The standard is harmonized with ISO 14971. A full risk analysis must document how each alarm condition (apnea, bradycardia, etc.) is mitigated.
- Alarm system design — Follow IEC 60601-1-8 for alarm prioritization (high priority for apnea and bradycardia) and signal characteristics.
- Clinical validation — Evidence of clinical performance (sensitivity, specificity, positive predictive value) during apnea episodes must be provided. This is especially important for Class II and III monitors.
- Labeling and instructions — Marking must clearly state the class of the monitor, intended patient population, and any contraindications. Instructions must include alarm-setting guidelines and troubleshooting.
- Environmental robustness — Devices must pass tests for drop, shock, vibration, and temperature/humidity per IEC 60601-1-11 (home healthcare) if intended for home use.
Best Practice: Early engagement with a Health Canada recognized certification body (e.g., CSA Group, Intertek, UL) can help identify gaps before formal testing. Use the CSA Z18778-08 checklist available in the standard’s annexes.
Compliance and Certification in Canada
CAN/CSA Z18778-08 is recognized by Health Canada as a conformity assessment standard for infant monitors classified under Class II of the Canadian Medical Devices Regulations (SOR/98-282). Manufacturers wishing to sell an infant monitor in Canada must follow the applicable regulatory pathway, typically requiring a Medical Device License (MDL) or a Medical Device Establishment License (MDEL) depending on device classification and manufacturer location.
The standard may be used to demonstrate substantial equivalence or compliance with the Essential Principles of Safety and Effectiveness. The Canadian adoption includes no national deviations, so testing performed to ISO 18778:2008 is generally accepted as equivalent to CAN/CSA Z18778-08. However, a formal “Declaration of Conformity” referencing the Canadian standard is advisable when applying for a Medical Device License.
Testing should be performed by a laboratory accredited to ISO/IEC 17025. The test report must cover all clauses of CAN/CSA Z18778-08, including the accuracy tables for apnea timing and heart rate. In addition, the manufacturer must submit a summary of clinical data, risk management file (ISO 14971), and a description of the alarm system per IEC 60601-1-8.
Note: Failure to meet the artifact rejection requirements or alarm timing can result in a refusal from Health Canada. More than 30% of infant monitor submissions in a recent audit were returned due to insufficient apnea alarm test data — ensure your test protocol is comprehensive.
Conclusion
CAN/CSA Z18778-08 sets rigorous safety and performance benchmarks for infant monitors in Canada. By requiring precise apnea detection, artifact rejection, and multi-parameter alarming, the standard helps reduce the risk of SIDS, bradycardia events, and hypoxemic episodes in vulnerable infants. Manufacturers should adopt a structured design‑control process that addresses the technical requirements early and use recognized testing laboratories for pre‑compliance evaluation.
Frequently Asked Questions
Q: What is the difference between CAN/CSA Z18778-08 and ISO 18778:2008?
A: The two documents are technically identical — CAN/CSA Z18778-08 is an adoption of ISO 18778:2008 without national deviations. The main difference is the designation for Canadian regulatory use. Testing performed to either version is generally accepted by Health Canada, but the CSA version explicitly references the Canadian Medical Devices Regulations.
A: The two documents are technically identical — CAN/CSA Z18778-08 is an adoption of ISO 18778:2008 without national deviations. The main difference is the designation for Canadian regulatory use. Testing performed to either version is generally accepted by Health Canada, but the CSA version explicitly references the Canadian Medical Devices Regulations.
Q: Is compliance with CAN/CSA Z18778-08 mandatory in Canada?
A: It is not mandatory in law (i.e., no order in council mandate), but it is a recognized standard for demonstrating conformity to the Essential Principles. Health Canada typically expects manufacturers of infant monitors to follow a standard like this as part of the Medical Device License application. Not using a recognized standard makes the submission more difficult and increases regulatory risk.
A: It is not mandatory in law (i.e., no order in council mandate), but it is a recognized standard for demonstrating conformity to the Essential Principles. Health Canada typically expects manufacturers of infant monitors to follow a standard like this as part of the Medical Device License application. Not using a recognized standard makes the submission more difficult and increases regulatory risk.
Q: Does CAN/CSA Z18778-08 apply to pulse oximeters used alone (not combined with an apnea monitor)?
A: No — the standard specifically addresses monitors that include at least a respiration sensor. Standalone pulse oximeters for infant use fall under ISO 80601-2-61 and the general medical electrical equipment standard. However, if the device is a combined monitor (e.g., apnea + SpO2), then the pulse oximetry portion must also meet the requirements of ISO 80601-2-61.
A: No — the standard specifically addresses monitors that include at least a respiration sensor. Standalone pulse oximeters for infant use fall under ISO 80601-2-61 and the general medical electrical equipment standard. However, if the device is a combined monitor (e.g., apnea + SpO2), then the pulse oximetry portion must also meet the requirements of ISO 80601-2-61.
Q: Are there specific marking or labeling requirements under this standard?
A: Yes. Clause 6 of CAN/CSA Z18778-08 requires the monitor’s class (I, II, or III) to be marked on the device, together with alarm thresholds and sensor type. Instructions must be in both English and French for the Canadian market. Additionally, the user manual must explain the risk of false alarms and how to reduce them without disabling safety functions.
A: Yes. Clause 6 of CAN/CSA Z18778-08 requires the monitor’s class (I, II, or III) to be marked on the device, together with alarm thresholds and sensor type. Instructions must be in both English and French for the Canadian market. Additionally, the user manual must explain the risk of false alarms and how to reduce them without disabling safety functions.
Article prepared for technical reference. Last updated 2026. Always consult the latest version of CAN/CSA Z18778 and Health Canada guidance for current compliance requirements.